Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Medicinal Chemistry, Drug Discovery and Drug Delivery .
To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Medicinal Chemistry, Drug Discovery and Drug Delivery .
28 July, 2021
Early Bird Registration
28 May, 2021
October 25-27, 2021
Director of UTCoP Drug Discovery Center The University of Tennessee Health Science Center
Dr. Li is currently a Distinguished Professor at UTHSC, Director of UTCoP Drug Discovery Center, and the Faculty Director of the Shared Analytical Instruments at UTHSC. He is also the Founder and CSO of SEAK Therapeutics LLC. Dr. Li obtained his BS degree from the University of Science and Technology of China and his PhD degree from Columbia University in 1999, both in chemistry. His research focus is small molecule drug discovery. He has published over 170peer-reviewed papers, four book chapters, and 12 issued US patents. Dr. Li has been a grant reviewer for US government, state, and foreign funding agencies. He is also a frequent reviewer for journal articles and is an editorial board member for several journals.
The University of SydneyAustralia
Professor (David) Dagan Feng is Director, Biomedical & Multimedia Information Technology (BMIT) Research Group, and also Funding Head, School of Information Technology (renamed as Computer Science recently) and Funding Director, Institute of Biomedical Engineering and Technology Institute, the University of Sydney. He received his ME in Electrical Engineering & Computer Science (EECS) from Shanghai Jiao Tong University in 1982, MSc in Biocybernetics and PhD in Computer Science from the University of California, Los Angeles (UCLA) in 1985 and 1988 respectively, where he received the Crump Prize for Excellence in Medical Engineering. In conjunction with his team members and students, he has been responsible for more than 50 key research projects, published over 900 scholarly research papers, pioneered several new research directions, and made a number of landmark contributions in his field. He has served as Chair of the International Federation of Automatic Control (IFAC) Technical Committee on Biological and Medical Systems, Special Area Editor / Associate Editor / Editorial Board Member for a dozen of core journals in his area, and Scientific Advisor for a number of prestigious organizations. He has been invited to give over 100 keynote presentations in 23 countries and regions, and has organized / chaired over 100 major international conferences / symposia / workshops. Professor Feng is Fellow of ACS, HKIE, IET, IEEE, and Australian Academy of Technological Sciences and Engineering.
Palacky University OlomoucCzech Republic
Josef Jampilek completed his Ph.D. degree in Medicinal Chemistry at the Faculty of Pharmacy of the Charles University (Czech Republic) in 2004. In 2004-2011, he worked in expert and managerial posts in the R&D Division of the pharmaceutical company Zentiva (Czech Republic). Prof. Jampilek deepened his professional knowledge at the Medicinal Chemistry Institute of the Heidelberg University (Germany) and at multiple specialized courses. In 2017, he was designated as a Full Professor of Medicinal Chemistry. At present he works at the Regional Centre of Advanced Technologies and Materials, Palacky University in Olomouc (Czech Republic) and the Faculty of Natural Sciences, Comenius University in Bratislava (Slovakia). In addition, he is a visiting professor at the University of Silesia in Katowice (Poland) and Hong Kong Baptist University (Hong Kong SAR, China) and an invited professor/expert at various higher educational institutions. He is an author/co-author of more than 30 patents/patent applications, more than 200 peer-reviewed scientific publications, 7 university textbooks, more than 30 chapters in monographs, and many invited lectures at international conferences and workshops. He also received several awards for his scientific results, e.g., from Aventis, Elsevier, Willey, Sanofi and FDA. The research interests of Prof. Jampilek include design, synthesis, and structure-activity relationships of heterocyclic compounds as anti-invasive and anti-inflammatory agents as well as drug delivery nanosystems. He is also interested in ADME, drug bioavailability and solid-state pharmaceutical analysis.
University of Houston
Dr. Amin Firouzi received his Ph.D. in Materials Engineering from University of Rome – Tor Vergata, Italy in collaboration with Delft University of Technology, The Netherlands in 2014. Then, he joined the Department of Process Engineering at International Maritime College Oman as assistant professor and was promoted to the head of the department in 2017. Dr. Amin has established two research labs in this department through internal and external research funding. In 2020, he joined the Department of Biomedical Engineering at the University of Houston. Dr. Amin has served on several international scientific committees.His research interest is in the field of nanotechnology and mainly focused on synthesis, characterization and fabrication of nanomaterials/nanodevices for different applications.
King Saud University Saudi Arabia
Assem BARAKAT was born in Egypt in 1981. He got a B.Sc. Chemistry in 2002, Alexandria University, Egypt. He started his career as a Chemist at Pharco Pharmaceutical Company then moved into the Chemistry Department, College of Science Alexandria University through a government designation program for the 20 top ranked students. In 2006, he got a fellowship for one year for a young researcher at the University of Genoa, Italy. Subsequently, in 2007, he got a Ph.D. Scholarship program from Politecnico di Milano, Milano, Italy with a joint program with ETH, Zurich, Switzerland and University of Stuttgart, Germany which awarded the PhD degree in 2010. Barakat joined Pharos University in Alexandria, Egypt as Lecturer of Organic Chemistry in late 2010, then in early 2011, moved into King Saud University, Riyadh, Saudi Arabia as assistant Professor, then promoted into associate professor in 2017. Recently in Feb, 2021 he was promoted into full professor. He got some awards including Arab Chemistry Award in 2016 (Saudi Chemical Society Scientific Excellence Award for Youth Section). Research interests focus on drug discovery; protein-protein interaction inhibitor; asymmetric synthesis; and X-ray single crystallography. He has accomplished more than 180 articles and 3 patents. Supervised 6 Master and 3 PhD students up to now.